These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14657791)

  • 21. Intracellular biology of Alzheimer's disease amyloid beta peptide.
    Hartmann T
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):291-8. PubMed ID: 10653285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human beta-secretase (BACE) and BACE inhibitors: progress report.
    John V
    Curr Top Med Chem; 2006; 6(6):569-78. PubMed ID: 16712492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrogen sulfide reduces mRNA and protein levels of β-site amyloid precursor protein cleaving enzyme 1 in PC12 cells.
    Zhang H; Gao Y; Zhao F; Dai Z; Meng T; Tu S; Yan Y
    Neurochem Int; 2011 Feb; 58(2):169-75. PubMed ID: 21095213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In search of an enzyme: the beta-secretase of Alzheimer's disease is an aspartic proteinase.
    Howlett DR; Simmons DL; Dingwall C; Christie G
    Trends Neurosci; 2000 Nov; 23(11):565-70. PubMed ID: 11074266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Identification of a novel substrate of Alzheimer's beta-secretase: beta-secretase dependent cleavage of alpha 2,6 sialyltransferase].
    Kitazume S; Saido TC; Hashimoto Y
    Seikagaku; 2002 Sep; 74(9):1180-3. PubMed ID: 12402461
    [No Abstract]   [Full Text] [Related]  

  • 26. A new wrestler in the battle between alpha- and beta-secretases for cleavage of APP.
    Neve RL
    Trends Neurosci; 2003 Sep; 26(9):461-3. PubMed ID: 12948653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons.
    Cai H; Wang Y; McCarthy D; Wen H; Borchelt DR; Price DL; Wong PC
    Nat Neurosci; 2001 Mar; 4(3):233-4. PubMed ID: 11224536
    [No Abstract]   [Full Text] [Related]  

  • 28. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
    Halliday G; Robinson SR; Shepherd C; Kril J
    Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice.
    Park IH; Hwang EM; Hong HS; Boo JH; Oh SS; Lee J; Jung MW; Bang OY; Kim SU; Mook-Jung I
    Neurobiol Aging; 2003 Sep; 24(5):637-43. PubMed ID: 12885571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel drug target in Alzheimer's disease.
    Bornebroek M; Kumar-Singh S
    Lancet; 2004 Nov 13-19; 364(9447):1738-9. PubMed ID: 15541434
    [No Abstract]   [Full Text] [Related]  

  • 31. BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic character.
    Clarke B; Demont E; Dingwall C; Dunsdon R; Faller A; Hawkins J; Hussain I; MacPherson D; Maile G; Matico R; Milner P; Mosley J; Naylor A; O'Brien A; Redshaw S; Riddell D; Rowland P; Soleil V; Smith KJ; Stanway S; Stemp G; Sweitzer S; Theobald P; Vesey D; Walter DS; Ward J; Wayne G
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1017-21. PubMed ID: 18166458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tarenflurbil: a shot on goal.
    Aisen PS
    Lancet Neurol; 2008 Jun; 7(6):468-9. PubMed ID: 18450518
    [No Abstract]   [Full Text] [Related]  

  • 33. New therapies. New Alzheimer's treatments that may ease the mind.
    Helmuth L
    Science; 2002 Aug; 297(5585):1260-2. PubMed ID: 12193764
    [No Abstract]   [Full Text] [Related]  

  • 34. gamma-Secretase as a target for drug intervention in Alzheimer's disease.
    Harrison T; Churcher I; Beher D
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):709-19. PubMed ID: 15503873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular and molecular basis of beta-amyloid precursor protein metabolism.
    Greenfield JP; Gross RS; Gouras GK; Xu H
    Front Biosci; 2000 Jan; 5():D72-83. PubMed ID: 10702374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease.
    Tomita T
    Adv Biol Regul; 2017 May; 64():33-38. PubMed ID: 28082052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific enzyme identified that snips APP into beta-amyloid.
    Senior K
    Drug Discov Today; 2005 Nov; 10(21):1408. PubMed ID: 16243255
    [No Abstract]   [Full Text] [Related]  

  • 38. Shutting down Alzheimer's.
    Wolfe MS
    Sci Am; 2006 May; 294(5):72-9. PubMed ID: 16708491
    [No Abstract]   [Full Text] [Related]  

  • 39. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.
    Yan R; Bienkowski MJ; Shuck ME; Miao H; Tory MC; Pauley AM; Brashier JR; Stratman NC; Mathews WR; Buhl AE; Carter DB; Tomasselli AG; Parodi LA; Heinrikson RL; Gurney ME
    Nature; 1999 Dec; 402(6761):533-7. PubMed ID: 10591213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-site specific intrabodies to decrease and prevent generation of Alzheimer's Abeta peptide.
    Paganetti P; Calanca V; Galli C; Stefani M; Molinari M
    J Cell Biol; 2005 Mar; 168(6):863-8. PubMed ID: 15767460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.